Former Chief Medical Officer · Cartesian Therapeutics, Inc. (RNAC)

Peter Traber

A named executive officer of Cartesian Therapeutics in every fiscal year CompBrief holds from FY2020 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$3,780,920

Salary $458,920Stock awards $226,000Bonus $850,000

FY2022: $2,003,983

2nd of 6 named executive officers at Cartesian Therapeutics by FY2023 total.

6 named officers on file for Cartesian Therapeutics, FY2023

Peter Traber’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 4 equity grants, each cited to its filing
  • RNAC’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Cartesian Therapeutics’s whole pay program stands against its peers

  • Cartesian Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on RNAC→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 26, 2024 (DEF 14A).

Free

Get Peter Traber’s full pay file as a PDF — free

More than this page: up to 10 years of Peter’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Peter Traber compensation by year

Cartesian Therapeutics Summary Compensation Table · all 4 fiscal years held
In US dollars, as Cartesian Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022FY2023
Salary$177,692$440,000$455,573$458,920
Bonus$75,000$0$0$850,000
Stock awards$0$253,445$298,562$226,000
Option awards$1,174,027$704,679$1,035,133$793,170
Non-equity incentive$84,333$181,000$183,568$0
Pension and deferred compensation$0$0$0$0
All other$1,805$21,561$31,147$1,452,830
Total$1,512,857$1,600,685$2,003,983$3,780,920

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cartesian Therapeutics, Inc. DEF 14A filed April 26, 2024, accession 0001453687-24-000076, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Cartesian Therapeutics, Inc. filed document, accession 0001453687-24-000076. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2024.

$1.5M
$1.6M
$2.0M
$3.8M
FY20
FY21
FY22
FY23
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU38,000$123,880—
RSU9,100$29,666—
Option230,000—$2.99
Option54,400—$4.32
Option433,333—$2.38

Per the Outstanding Equity Awards at Fiscal Year-End table in Cartesian Therapeutics, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Cartesian Therapeutics’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Carsten BrunnPresident and Chief Executive Officer$6,111,883
Peter Traber · this pageFormer Chief Medical Officer$3,780,920
Lloyd JohnstonFormer Chief Operations Officer$2,697,590
Blaine DavisChief Financial Officer$2,494,759
Metin KurtogluChief Technology Officer$71,243
Chris JewellChief Scientific Officer$53,100

The full Cartesian Therapeutics compensation record

free company brief

This page is one person within Cartesian Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Cartesian Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Cartesian Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Peter Traber's compensation dossier · One-time report. No refunds.